Detalles de la búsqueda
1.
Second-line and third-line therapy with nanoliposomal irinotecan (nal-IRI) in pancreatic cancer: a single-center experience and review of literature.
J Gastrointest Oncol
; 14(1): 352-365, 2023 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36915455
2.
Efficacy and tolerability of fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in unselected patients with advanced gastric and gastroesophageal cancer: does age really matter?
J Cancer Res Clin Oncol
; 149(5): 1849-1862, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35763109
3.
Impact of regular additional endobiliary radiofrequency ablation on survival of patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy.
Sci Rep
; 12(1): 1011, 2022 01 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35046437
4.
Multimodal and systemic therapy with cabozantinib for treatment of recurrent hepatocellular carcinoma after liver transplantation: A case report with long term follow-up outcomes.
Medicine (Baltimore)
; 100(38): e27082, 2021 Sep 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34559100
5.
Alpha-Fetoprotein- and CD40Ligand-Expressing Dendritic Cells for Immunotherapy of Hepatocellular Carcinoma.
Cancers (Basel)
; 13(13)2021 Jul 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34282787
6.
First Line and Second Line Chemotherapy in Advanced Cholangiocarcinoma and Impact of Dose Reduction of Chemotherapy: A Retrospective Analysis.
Front Oncol
; 11: 717397, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34858809
Resultados
1 -
6
de 6
1
Próxima >
>>